Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004-2009

Lung Cancer

Volumn 86, Issue 1, 2014, Pages 22-28

  Houston, Keisha A ^a   Henley, S Jane ^a   Li, Jun ^a   White, Mary C ^a   Richards, Thomas B ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

Histologic type; Incidence; Lung cancer; Surveillance; Time trend; Tumor registry

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER REGISTRY; CONTROLLED CLINICAL TRIAL (TOPIC); ETHNIC GROUP; FEMALE; GEOGRAPHIC DISTRIBUTION; HISTOPATHOLOGY; HUMAN; INCIDENCE; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; OVERALL SURVIVAL; POPULATION; SEX DIFFERENCE; SMALL CELL LUNG CANCER; UNITED STATES; HISTORY; LUNG NEOPLASMS; MIDDLE AGED; PATHOLOGY; REGISTER; RISK; RISK FACTOR; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HISTORY, 21ST CENTURY; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; REGISTRIES; RISK FACTORS; SEER PROGRAM; UNITED STATES; YOUNG ADULT;

EID: 84908463682     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2014.08.001     Document Type: Article

References (57)

1. U.S. Department of Health and Human Services. United States cancer statistics: 1999-2009 incidence and mortality web-based report; 1999-2009 [cited 2013; Available from:]. http://www.cdc.gov/uscs.
2. Travis W.D., Brambilla E., Muller-Hermelink H.K., Harris C.C.(Eds.) World Health Organization Classification of Tumors Pathology and Genetics of Tumors of the Lung, Pleura. Thymus and Heart 2004, IARC Press, Lyon.
3. Travis W., Brambilla E., Van Schil P., Scagliotti G., Huber R., Sculier J., et al. Paradigm shifts in lung cancer as defined in the new IASLC/ATS/ERS lung adenocarcinoma classification. Eur Respir J 2011, 38:239-243.
4. Johnson C., Peace S., Adamo P., Fritz A., Percy-Laurry A., Edwards B. The 2007 multiple primary and histology coding rules 2007, National Cancer Institute, Surveillance, Epidemiology and End Results Program, Bethesda, MD.
5. Langer C., Besse B., Gualberto A., Brambilla E., Soria J. The evolving role of histology in the management of advanced non-small-cell lung cancer. J Clin Oncol 2010, 28:5311-5320.
6. Kulesza P., Ramchandran K., Patel J. Emerging concepts in the pathology and molecular biology of advanced non-small cell lung cancer. Am J Clin Pathol 2011, 136:228-238.
7. Govindan R., Page N., Morgensztern D., Read W., Tierney R., Vlahiotis A., et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 2006, 24:4539-4544.
8. Devesa S., Shaw G., Blot W. Changing patterns of lung cancer incidence by histological type. Cancer Epidemiol Biomark Prev 1991, 1:29-34.
9. Wynder E.L., Muscat J.E. The changing epidemiology of smoking and lung cancer histology. Environ Health Perspect 1995, 103:143-148.
10. Vincent R., Pickren J., Lane W., Bross I., Takita H., Houten L., et al. The changing histopathology of lung cancer: a review of 1682 cases. Cancer 1977, 39:1647-1655.
11. Travis W., Lubin J., Ries L., Devesa S. United States lung carcinoma incidence trends: declining for most histologic types among males, increasing among females. Cancer 1996, 77:2464-2470.
12. Underwood J., Townsend J., Tai E., Davis S., Stewart S., White A., et al. Racial and regional disparities in lung cancer incidence. Cancer 2012, 118:1910-1918.
13. Valaitis J., Warren S., Gamble D. Increasing incidence of adenocarcinoma of the lung. Cancer 1981, 47:1042-1046.
14. Zheng T., Holford T., Boyle P., Chen Y., Ward B., Flannery J., et al. Time trend and the age-period-cohort effect on the incidence of histologic types of lung cancer in Connecticut, 1960-1989. Cancer 1994, 74:1556-1567.
15. Chen F., Cole P., Bina W., Time Trend Geographic patterns of lung adenocarcinoma in the United States, 1973-2002. Cancer Epidemiol Biomark Prev 2007, 16:2724-2729.
16. Young J.J., Roffers S., Ries L., Fritz A., AA H.E. SEER summary staging manual-2000: codes and coding instructions 2001, (Report no. 01-4969), National Cancer Institute, Bethesda, MD.
17. International classification of diseases for oncology 2000, World Health Organization, Geneva, Switzerland. 3rd ed. A. Fritz, C. Percy, A. Jack, K. Shanmugaratnam, L. Sobin, D.M. Parkin, S. Whelan (Eds.).
18. Surveillance Research Program NCI. SEER*Stat software version 8.01. Available from: 〈seer.cancer.gov/seerstat〉.
19. Stellman S., Muscat J.E., Thompson S., Hoffmann D., Wynder E. Risk of squamous cell carcinoma and adenocarcinoma of the lung in relation to lifetime filter cigarette smoking. Cancer 1997, 80:382-388.
20. U.S.Department of Health and Human Services The health consequences of smoking: 50 years of progress. A report of the surgeon general 2014, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA.
21. Burns D., Anderson C. Do changes in cigarette design influence the rise in adenocarcinoma of the lung. Cancer Causes Control 2011, 22:13-22.
22. Hoffmann D., Hoffmann I. The changing cigarette, 1950-1995. J Toxicol Environ Health 1997, 50(4):307-364.
23. National Cancer Institute Risks Associated With Smoking Cigarettes With Low Machine-Measured Yields of Tar and Nicotine. Smoking and Tobacco Control Monograph No. 13. Bethesda (MD): U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, 2001. NIH Publication no. 02-5047.
24. Brooks D.R., Austin J.H., Heelan R.T., Ginsberg M.S., Shin V., Olson S.H., et al. Influence of type of cigarette on peripheral versus central lung cancer. Cancer Epidemiol Biomark Prev 2005, 14:576-581.
25. Stepanov I., Knezevich A., Zhang L., Watson C.H., Hatsukami D.K., Hecht S.S. Carcinogenic tobacco-specific N-nitrosamines in US cigarettes: three decades of remarkable neglect by the tobacco industry. Tob Control 2012, 21(1):44-48.
26. Jemal A., Thun M., Ries L., Howe H., Weir H., Center M., et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 2008, 100:1672-1694.
27. Fiore M. Trends in cigarette smoking in the United States. The epidemiology of tobacco use. Med Clin North Am 1992, 76:289-303.
28. Pierce J., Fiore M., Novotny T., Hatziandreu E., Davis R. Trends in cigarette smoking in the United States. Projections to the year 2000. J Am Med Assoc 1989, 261:61-65.
29. Lortet-Tieulent J., Soerjomataram I., Ferlay J., Rutherford M., Weiderpass E., Bray F. International trends in lunc cancer incidence by histological subtype:adenocarcinoma stabilizing in men but still increasing in women. Lung Cancer 2014, 84:13-22.
30. Fiore M., Novotny T., Pierce J., Hatziandreu E., Patel K., Davis R. Trends in cigarette smoking in the United States. The changing influence of gender and race. J Am Med Assoc 1989, 261.
31. U.S. Department of Health and Human Services. Reducing the health consequences of smoking: 25 years of progress. A Report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1989.
32. Wynder E., Graham E. Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma; a study of 684 proved cases. J Am Med Assoc 1950, 143:329-336.
33. Harris R., Zang E., Anderson J., Wynder E. Race and sex differences in lung cancer risk associated with cigarette smoking. Int J Epidemiol 1993, 22:592-599.
34. Hinds M., Stemmermann G., Yang H., Kolonel L., Lee J., Wegner E. Differences in lung cancer risk from smoking among Japanese, Chinese and Hawaiian women in Hawaii. Int J Cancer 1981, 27:297-302.
35. Pesch B., Kendzia B., Gustavsson P., Jöckel K., Johnen G., Pohlabeln H.O.A., et al. Cigarette smoking and lung cancer-relative risk estimates for the major histological types from a pooled analysis of case-control studies. Int J Cancer 2012, 131:1210-1219.
36. Metayer C., Wang Z., Kleinerman R., Wang L., Brenner A., Cui H., et al. Cooking oil fumes and risk of lung cancer in women in rural Gansu, China. Lung Cancer 2002, 35:111-117.
37. Ko Y., Lee C., Chen M., Huang C., Chang W., Lin H., et al. Risk factors for primary lung cancer among non-smoking women in Taiwan. Int J Epidemiol 1997, 26:24-31.
38. Tsao M., Zhu H., Giaid A., Viallet J., Nakamura T., Park M. Hepatocyte growth factor/scatter factor is an autocrine factor for human normal bronchial epithelial and lung carcinoma cells. Cell Growth Differ 1993, 4:571-579.
39. Taioli E., Wynder E. Endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst 1994, 86:869-870.
40. Seow A., Poh W., Teh M., Eng P., Wang Y., Tan W., et al. Diet, reproductive factors and lung cancer risk among Chinese women in Singapore: evidence for a protective effect of soy in nonsmokers. Int J Cancer 2002, 97:365-371.
41. Liao M., Wang J., Wang H., Ou A., Wang X., You W. A study of the association between squamous cell carcinoma and adenocarcinoma in the lung, and history of menstruation in Shanghai women, China. Lung Cancer 1996, 14:S215-S221.
42. Li Y., Tsai Y., Chen Y., Christiani D. Human papilloma virus and female lung adenocarcinoma. Semin Oncol 2009, 36:542-552.
43. Siegel R., Naishadham D., Jemal A. Cancer statistics for Hispanics/Latinos, 2012. CA Cancer J Clin 2012, 62(5):283-298.
44. Kelly J.J., Lanier A.P., Alberts S., Wiggins C.L. Differences in cancer incidence among Indians in Alaska and New Mexico and U S. Whites, 1993-2002. Cancer Epidemiol Biomark Prev 2006, 15:1515-1519.
45. Bliss A., Cobb N., Solomon T., Cravatt K., Jim M., Marshall L. Cancer 2008, 113(5 Suppl):S1169-S1178.
46. Van Schil P.E., Sihoe A.D., Travis W.D. Pathologic classification of adenocarcinoma of lung. J Surg Oncol 2013, 108(5):320-326.
47. Travis W.D., Brambilla E., Riely G.J. New pathologic classification of lung cancer: relevance for clinical practice and clinical trials. J Clin Oncol 2013, 31(8):992-1001.
48. National Lung Screening Trial Research Team Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011, 365:395-409.
49. National Lung Screening Trial Research Team, Church T.R., Black W.C., Aberle D.R., Berg C.D., Clingan K.L., et al. Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med 2013, 368(21):1980-1991.
50. Aberle D.R., DeMello S., Berg C.D., Black W.C., Brewer B., Church T.R., et al. Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med 2013, 369(10):920-931.
51. Pinsky P.F., Church T.R., Izmirlian G., Kramer B.S. The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology. Cancer 2013, 119(22):3976-3983.
52. National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Version 2.2014. Available from: http://www.nccn.org/.
53. Pinsky P., Black B. Subset and histological analysis of screening efficacy in the national lung screening trial. 2nd Joint Meeting of the National Cancer Advisory Board and Board of Scientific Directors 2013.
54. Smith R.A1, Manassaram-Baptiste D., Brooks D., Cokkinides V., Doroshenk M., Saslow D., et al. Cancer screening in the United States, 2014: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 2014, 64:30-51.
55. Richards T.B., White M.C., Caraballo R.S. Lung cancer screening with low-dose computed tomography for primary care providers. Prim Care Clin Office Pract 2014, 41:307-330.
56. Espey D.K., Wiggins C.L., Jim M.A., Miller B.A., Johnson C.J., TM B. Methods for improving cancer surveillance data in American Indian and Alaska Native populations. Cancer 2008, 113:1120-1130.
57. NAACCR Latino Research Work Group. NAACCR guideline for enhancing Hispanic/Latino identification: Revised NAACCR Hispanic/Latino identification algorithm [NHIA v2.1]. Springfield, IL: North American Association of Central Cancer Registries; 2008.